Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRambam Health Care Campus
About this trial
Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
Eligibility criteria
Qualifiers
Singleton pregnancy
Maternal age ≥ 18 years' old
Oxytocin administration initiated or renewed during second stage of labor
Disqualifiers
Maternal age < 18 years' old
Multiple gestation pregnancy
Known fetal malformations
Uterine scar
Trial design
Treatments tested in this trial
- Oxytocin
Treatment groups
120 Participants
are divided into 2 treatment groupsLocations
1Rambam medical health campus31999, Haifa Israel
Sponsors and collaborators
Rambam Health Care Campus
Lead sponsor
Source ClinicalTrials.gov